Scientists have identified a novel two-pronged treatment method, offering significant potential for patients battling advanced prostate cancer. Experts at The Institute of Cancer Research, London, ...
Roquefort Therapeutics is acquiring exclusive worldwide rights to a clinical-stage tumour inhibitor for £32m in an all-paper deal and raising £8.5 million.
NEW ORLEANS — A schoolteacher wants to keep other men from going through the same late-stage health diagnosis that he did. It's one that could have cost him his life at a young age. He tells us why he ...
The methods of diagnosing and treating localised prostate cancer has changed significantly in the last two decades.
According to the Uganda Cancer Institute (UCI), several factors contribute to the high burden of oncologic emergencies in Uganda, with late diagnosis being among the most significant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results